Literature DB >> 17947997

The mouse cornea micropocket angiogenesis assay.

Michael S Rogers1, Amy E Birsner, Robert J D'Amato.   

Abstract

The mouse corneal micropocket angiogenesis assay uses the avascular cornea as a canvas to study angiogenesis in vivo. Through the use of standardized slow-release pellets, a predictable angiogenic response is generated over the course of 5 d and then quantified. Uniform slow-release pellets are prepared by mixing purified angiogenic growth factors such as basic fibroblast growth factor or vascular endothelial growth factor with sucralfate (a stabilizer) and Hydron (poly-HEMA (poly(2-hydroxyethyl methacrylate)) to allow slow release). This mixture is applied to a mesh that controls unit size and then allowed to harden. A micropocket is surgically created in the mouse cornea and a pellet implanted. Five days later, the area of the cornea overgrown by the angiogenic response is measured using a slit lamp. A skilled investigator can implant and grade 40 eyes in about 2.5 h. The results of the assay are used to assess the ability of potential therapeutic molecules or genetic differences to modulate angiogenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17947997     DOI: 10.1038/nprot.2007.368

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  62 in total

1.  Mouse corneal lymphangiogenesis model.

Authors:  Renhai Cao; Sharon Lim; Hong Ji; Yin Zhang; Yunlong Yang; Jennifer Honek; Eva-Maria Hedlund; Yihai Cao
Journal:  Nat Protoc       Date:  2011-05-19       Impact factor: 13.491

2.  Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury.

Authors:  Rongxue Wu; Kirsten M Smeele; Eugene Wyatt; Yoshihiko Ichikawa; Otto Eerbeek; Lin Sun; Kusum Chawla; Markus W Hollmann; Varun Nagpal; Sami Heikkinen; Markku Laakso; Kentaro Jujo; J Andrew Wasserstrom; Coert J Zuurbier; Hossein Ardehali
Journal:  Circ Res       Date:  2010-11-11       Impact factor: 17.367

3.  Repulsive axon guidance molecule Slit3 is a novel angiogenic factor.

Authors:  Bing Zhang; Ursula M Dietrich; Jian-Guo Geng; Roy Bicknell; Jeffrey D Esko; Lianchun Wang
Journal:  Blood       Date:  2009-09-09       Impact factor: 22.113

4.  Genetic loci that control the size of laser-induced choroidal neovascularization.

Authors:  Kei Nakai; Michael S Rogers; Takashi Baba; Taisaku Funakoshi; Amy E Birsner; Dema S Luyindula; Robert J D'Amato
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

5.  Differential distribution of blood and lymphatic vessels in the murine cornea.

Authors:  Tatiana Ecoiffier; Don Yuen; Lu Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-17       Impact factor: 4.799

Review 6.  Following up tumour angiogenesis: from the basic laboratory to the clinic.

Authors:  José L Orgaz; Beatriz Martínez-Poveda; Nuria I Fernández-García; Benilde Jiménez
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

7.  The albino mutation of tyrosinase alters ocular angiogenic responsiveness.

Authors:  Michael S Rogers; Irit Adini; Aaron F McBride; Amy E Birsner; Robert J D'Amato
Journal:  Angiogenesis       Date:  2013-02-20       Impact factor: 9.596

8.  Sema3A maintains corneal avascularity during development by inhibiting Vegf induced angioblast migration.

Authors:  Chelsey C McKenna; Ana F Ojeda; James Spurlin; Sam Kwiatkowski; Peter Y Lwigale
Journal:  Dev Biol       Date:  2014-05-06       Impact factor: 3.582

9.  Cathepsin B-mediated CD18 shedding regulates leukocyte recruitment from angiogenic vessels.

Authors:  Shintaro Nakao; Souska Zandi; Dawei Sun; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2017-09-13       Impact factor: 5.191

10.  An integrated approach to quantitative modelling in angiogenesis research.

Authors:  Anthony J Connor; Radosław P Nowak; Erica Lorenzon; Markus Thomas; Frank Herting; Stefan Hoert; Tom Quaiser; Eliezer Shochat; Joe Pitt-Francis; Jonathan Cooper; Philip K Maini; Helen M Byrne
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.